| Document Date: 2014-07-11 04:53:22
Open Document File Size: 1,03 MBShare Result on Facebook
City Brussels / / Company BioGeneration Ventures / Forbion Capital Partners / arGEN-X N.V. / Portfolio Company / Shire / / Continent Europe / / Country United States / Netherlands / / Currency EUR / / Event IPO / Funding / Second Stock Issuance / Product Release / Company Expansion / / IndustryTerm biopharmaceutical / treatment of cancer / / Person Edward van Wezel / / Position Managing Partner / / Product Closing / / Technology antibodies / / |
BioGeneration Ventures Announces Closing of Initial Public Offering of Portfolio Company arGEN-X Naarden, The Netherlands, 9 July 2014 – BioGeneration Ventures is proud to announce that its portfolio company arGEN-